Haptoglobin is a natural regulator of Langerhans cell function in the skin

Journal of Dermatological Science

Volumn 24, Issue 1, 2000, Pages 25-37

  Xie, Yong ^a,c   Li, Yanhua ^b   Zhang, Qiang ^a   Stiller, Matthew J ^c   Wang, C L Albert ^b   Streilein, J Wayne ^a,c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acute phase reactants; Dendritic cells; Immunomodulator; Skin

Indexed keywords

ACUTE PHASE PROTEIN; CD40 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HAPTOGLOBIN; HLA B7 ANTIGEN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOLESCENT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL TRANSFORMATION; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; SKIN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; CELL COMMUNICATION; CELLS, CULTURED; FEMALE; HAPTOGLOBINS; HUMANS; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 0033840280     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(00)00078-5     Document Type: Article

References (35)

1. Streilein J.W., Grammer S.F., Yoshikawa T., Demidem A., Vermeer M. Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes. Immunol. Rev. 117:1990;159-183.
2. Dai R., Grammer S.F., Streilein J.W. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells. J. Immunol. 150:1993;59-66.
3. Hufler C., Koch F., Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167:1988;700-705.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
5. Watts C. Inside the gearbox of the dendritic cell. Nature. 388:1997;724-725.
6. Cella M., Engering A., Pinet V., Pieters J., Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:1997;782-787.
7. Pierre P., Turley S.J., Gatti E., Hull M., Meltzer J., Steinman R.M., Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 338:1997;787-792.
8. Romani N., Koide S., Crowley M., Witmer-Pack M., Livingston A.M., Fathman C.G., Inaba Y., Steinman R.E. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169:1989;1169-1178.
9. Streilein J.W., Grammer S.F. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J. Immunol. 143:1989;3925-3933.
10. Kampgen E., Koch K., Romani N., Schuler G. Understanding the dendritic cell lineage through a study of cytokine receptors. J. Exp. Med. 179:1994;1767-1776.
11. Ozawa H., Aiba S., Nakagawa S., Tagami H. The regulation of ICAM-1 and B7 expression on murine Langerhans cells in vivo and in vitro. J. Invest. Dermatol. 102:1994;586.
12. Xie Y., Streilein J.W., Lopez D. Epidermal Langerhans cells from mice bearing a GM-CSF-producing mammary tumor display impaired accessory functions. Anticancer Res. 16:1996;9-16.
13. Xie Y., Streilein J.W. Regulation of Langerhans cell function via blood borne factor(s). J. Dermatol. Sci. 12:1996;263-274.
14. Xie Y., Streilein J.W. A heat-resistant serum factor that inhibits Langerhans cell maturation of diverse species, including man. J. Invest. Dermatol. 108:1997;610.
15. Kurosky A., Barnett D.R., Lee T.H., Bowman B.H., Fitch W.M. Covalent structure of human haptoglobin: a serine protease homolog. Proc. Natl. Acad. Sci. USA. 77:1980;3388-3392.
16. Yang F., Brune J.L., Baldwin W.D., Bowman B.H. Identification and characterization of human haptoglobin cDNA. Proc. Natl. Acad. Sci. USA. 80:1983;5875-5879.
17. Langlois M.R., Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42:1996;1589-1600.
18. Clerc C., Pibouin M., Ruelland A., Cloarec L. Cutaneous interstitial fluid protein concentrations in the inflammatory syndrome: pharmacological consequences. Clin. Chim. Acta. 189:1990;181-189.
19. Wagner L., Gessl A., Base W., Pasternack M.S. Haptolgobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytes. J. Immunol. 156:1989-1996;1996.
20. Snellman O., Sylven B. Haptoglobin acting as a natural inhibitor of cathepsin B activity. Nature. 216:1967;1033.
21. Pagano M., Nicola M.A., Engler R. Inhibition of cathepsin L and B by haptoglobin, the haptoglobin-hemoglobin complex, and asialohaptolgobin. 'In vitro' studies in the rat. Can. J. Biochem. 60:1982;631-637.
22. Y. Xie, G.P. Shi, Unpublished data.
23. Xu M., Capraro G.A., Daibata M., Humphreys R.E. Cathepsin B cleavage and release of invariant chain from MHC class II molecules follow a staged pattern. Mol. Immunol. 31:1994;723-731.
24. Cresswell P. Proteases, processing, and thymic selection. Science. 280:1998;394-395.
25. Pierre P., Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 93:1998;1135-1145.
26. Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:1990;707-716.
27. Ghmati S.M., Hoeyveld E.M., Ceuppens J.L., Stevens E.A. Identification of haptolgobin as an alternative ligand for CD11b/CD18. J. Immunol. 156:1996;2542-2552.
28. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
29. Demidem A., Taylor J.R., Streilein J.W. Comparative effects of CsA, TGFβ and chloroquine on alloantigen presenting cells of blood and epidermis. J. Invest. Dermatol. 96:1991;401-407.
30. Rantapaa D., Frohlander N. Haptoglobin groups and rheumatoid arthritis. Hum. Hered. 35:1985;207-211.
31. Rantapaa D., Beckman G., Beckman L. Serum protein markers in systemic lupus erythematosus. Hum. Hered. 38:1988;44-47.
32. Delanghe J., Van A.J., Verhofstede K., Plum J. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS. 12:1998;1027-1032.
33. Weissman D., Li Y., Orenstein J.M., Fauci A.S. Both a precursor and a mature population of dendritic cells can bind HIV. However, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells. J. Immunol. 155:1995;4111-4117.
34. Girolomoni G., Simon J., Bergstresser P.R., Cruz P.D. Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short term cultures. J. Immunol. 145:1990;2820-2826.
35. Dai R., Streilein J.W. In vitro culture allows splenic dendritic cells to reach their full potential for T cell activation. Reg. Immunol. 5:1993;269-278.